Bortezomib Impurity 10
| Product Name | Bortezomib Impurity 10 |
|---|---|
| Alternate Names | Bortezomib Impurities, Impurities of Bortezomib |
| CAT No. | CS-P-07309 |
| CAS No. | 390800-88-1 |
| Category | Impurities |
| Stock | Enquire |
| Mol. Wt. | 1098.7 g/mol |
| Mol. For. | C57H69B3N12O9 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Bortezomib |
| Therapeutic | Synthetic Peptides |
| Smileys | B1(OB(OB(O1)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C3=NC=CN=C3)C(CC(C)C)NC(=O)C(CC4=CC=CC=C4)NC(=O)C5=NC=CN=C5)C(CC(C)C)NC(=O)C(CC6=CC=CC=C6)NC(=O)C7=NC=CN=C7 |
| Canonical Smiles | B1(OB(OB(O1)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C3=NC=CN=C3)C(CC(C)C)NC(=O)C(CC4=CC=CC=C4)NC(=O)C5=NC=CN=C5)C(CC(C)C)NC(=O)C(CC6=CC=CC=C6)NC(=O)C7=NC=CN=C7 |
| InchIKey | YVBHFXUJMLXLKP-INZJBPCBSA-N |
| Inchl | InChI=1S/C57H69B3N12O9/c1-37(2)28-49(70-52(73)43(31-40-16-10-7-11-17-40)67-55(76)46-34-61-22-25-64-46)58-79-59(50(29-38(3)4)71-53(74)44(32-41-18-12-8-13-19-41)68-56(77)47-35-62-23-26-65-47)81-60(80-58)51(30-39(5)6)72-54(75)45(33-42-20-14-9-15-21-42)69-57(78)48-36-63-24-27-66-48/h7-27,34-39,43-45,49-51H,28-33H2,1-6H3,(H,67,76)(H,68,77)(H,69,78)(H,70,73)(H,71,74)(H,72,75)/t43-,44-,45-,49-,50-,51-/m0/s1 |
| IUPAC | N-[(2S)-1-[[(1R)-1-[4,6-bis[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]-1,3,5,2,4,6-trioxatriborinan-2-yl]-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
Pyrazine-2-carboxylic acid [1-(1-hydroxy-3-methyl-butyl carbamoyl)-2-phenyl-ethyl]-amide | Hydroxy Bortezomib | Bortezomib D-phenylalanyl analog | Bortezomib Impurity 6 | N-[2-[(3-methyl-1-oxobutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-2-Pyrazinecarboxamide | Bortezomib Impurity 9 | Bortezomib Impurity 55 | Bortezomib Dimer | Pyrazine-2-carboxylic acid(1-(3-methyl-butylcarbamoyl)-2-phenyl-ethyl)-amide | Bortezomib Impurity 3 (S-isomer) | Bortezomib Impurity 11 | Bortezomib Desphenylalanyl Analog | Bortezomib Hydroxy ketone analog | N-(1-(((R)-1-hydroxy-3-methylbutyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide | Bortezomib Impurity G | Bortezomib Impurity B | Bortezomib Impurity 32 | Bortezomib Impurity 29 | Bortezomib Impurity F | N-(1-((3-methyl-1-((3aS,4S,6S,7aS)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide | Bortezomib Impurity H | Pyrazine-2-carboxylic acid (1-[3-methyl-1-(2,9-dimethyl-3,5-dioxa-4-bora-tricyclo[6.1.1.0.2.6]dec-4-yl)-butylcarbamoyl]-2-phenyl-ethyl)-amide | Bortezomib impurity D | Bortezomib N-Formyl analog | Bortezomib Impurity C |